Nimorazole is a 5-nitroimidazole antibiotic and antiprotozoal medication used to treat anaerobic bacterial and parasitic infections, including trichomoniasis, giardiasis, amoebiasis, and acute ulcerative gingivitis. Nimorazole has been used in trials studying the treatment of Hypoxia, Radiotherapy, Hypoxic Modification, Gene Profile, Gene Signature, and Head and Neck Squamous Cell Carcinoma, among others. Its therapeutic use is listed as antibiotics, antiparasitics and antiprotozoals. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Naxogin and Nitrimidazine. Its PubChem CID is 23009.
Nimorazole
| CAS No | 6506-37-2 |
|---|---|
| Molecular Formula | C9H14N4O3 |
| Molecular Weight | 226.23 g/mol |
| Synonyms | 4-[2-(5-nitroimidazol-1-yl)ethyl]morpholine |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Nimorazole is a 5-nitroimidazole antibiotic and antiprotozoal medication used to treat anaerobic bacterial and parasitic infections, including trichomoniasis, giardiasis, amoebiasis, and acute ulcerative gingivitis.
The listed CAS number is 6506-37-2.
The listed molecular formula is C9H14N4O3.
The listed molecular weight is 226.23 g/mol.
4-[2-(5-nitroimidazol-1-yl)ethyl]morpholine.
The source lists Naxogin and Nitrimidazine.